Japan

JAPANESE PRODUCTS

EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.

Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.


Europe

EUROPEAN PRODUCTS

EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.

Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.


Middle East

MIDDLE EAST PRODUCTS

EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.

Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.


China

CHINA PRODUCTS

EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.

Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.


Mexico

MEXICO PRODUCTS

EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.

Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.


Canada

CANADA PRODUCTS

EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.

Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.


United States

UNITED STATES AND GLOBAL PRODUCTS INCLUDING CHINA

EmphyCorp’s Global N115 Technology has (7) U.S. Drug Patents and (3) Pending for all lung diseases.

Our technology is also globally patented in the USA, Canada, Mexico, Brazil, Japan, Australia, Europe, and China.